Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endo International PLC (NASDAQ:ENDP)

10.29
Delayed Data
As of Apr 21
 -0.19 / -1.81%
Today’s Change
9.70
Today|||52-Week Range
35.34
-37.52%
Year-to-Date
Biotech Movers: Organovo, Endo, Omeros
Apr 20 / TheStreet.com - Paid Partner Content
Are Options Traders Betting on a Big Move in Endo International (ENDP) Stock?
Apr 13 / Zacks.com - Paid Partner Content
Biotech Movers: Ultragenyx Jumps on Phase Three Burosumab Data
Apr 19 / TheStreet.com - Paid Partner Content
Endo (ENDP) Reports Preliminary Results for First Quarter
Apr 11 / Zacks.com - Paid Partner Content
IntelliPharmaCeutics (IPCI) Q1 Loss Narrower Than Expected
Apr 13 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close10.48
Today’s open10.47
Day’s range10.19 - 10.51
Volume5,835,433
Average volume (3 months)8,095,671
Market cap$2.3B
Dividend yield--
Data as of 3:59pm ET, 04/21/2017

Growth & Valuation

Earnings growth (last year)-96.37%
Earnings growth (this year)-23.71%
Earnings growth (next 5 years)-2.40%
Revenue growth (last year)+22.69%
P/E ratioNM
Price/Sales0.91
Price/Book0.85

Competitors

 Today’s
change
Today’s
% change
AXONAxovant Sciences Ltd-0.33-1.51%
IRWDIronwood Pharmaceuti...-0.16-1.00%
HCMHutchison China Medi...-0.18-0.97%
AGIOAgios Pharmaceutical...-1.29-2.67%
Data as of 4:00pm ET, 04/21/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)$1.11
Annual revenue (last year)$4.0B
Annual profit (last year)-$3.3B
Net profit margin-80.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul V. Campanelli
Chief Operating Officer &
Executive Vice President
Terrance J. Coughlin
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs